$97.2 Million is the total value of DAFNA Capital Management LLC's 47 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 40.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DSCO | Buy | DISCOVERY LABORATORIES INC | $12,822,000 | +223.0% | 5,698,739 | +181.3% | 13.20% | +204.3% |
| PCYC | Buy | PHARMACYCLICS INC | $11,491,000 | -18.6% | 108,628 | +6.4% | 11.83% | -23.3% |
| ATRC | Sell | ATRICURE INC | $8,531,000 | +62.7% | 456,701 | -4.4% | 8.78% | +53.2% |
| STXS | Buy | STEREOTAXIS INC | $6,293,000 | +19.2% | 1,738,498 | +9.7% | 6.48% | +12.3% |
| GIVN | GIVEN IMAGING | $4,702,000 | +56.4% | 156,320 | 0.0% | 4.84% | +47.4% | |
| NVDQ | NOVADAQ TECHNOLOGIES INC | $4,684,000 | -0.5% | 284,041 | 0.0% | 4.82% | -6.3% | |
| PLX | PROTALIX BIOTHERAPEUTICS INC | $4,584,000 | -14.1% | 1,178,440 | 0.0% | 4.72% | -19.1% | |
| PODD | Sell | INSULET CORP | $4,507,000 | -0.5% | 121,481 | -2.8% | 4.64% | -6.2% |
| INSULET CORPnote 3.750% 6/1 | $4,370,000 | +0.6% | 3,000,000 | 0.0% | 4.50% | -5.2% | ||
| NXTM | Buy | NXSTAGE MEDICAL INC | $3,842,000 | +16.0% | 384,154 | +52.7% | 3.95% | +9.3% |
| AMPE | AMPIO PHARMACEUTICALS INC | $3,035,000 | -4.9% | 425,703 | 0.0% | 3.12% | -10.4% | |
| MACK | Buy | MERRIMACK PHARMACEUTICALS IN | $1,826,000 | +165.8% | 342,453 | +89.0% | 1.88% | +150.2% |
| BEAT | Sell | BIOTELEMETRY INC | $1,712,000 | -44.0% | 215,645 | -30.1% | 1.76% | -47.3% |
| BOTA | Buy | BIOTA PHARMACEUTICALS INC | $1,371,000 | +62.2% | 327,190 | +61.8% | 1.41% | +52.9% |
| THLD | New | THRESHOLD PHARMACEUTICAL INC | $1,310,000 | – | 280,500 | +100.0% | 1.35% | – |
| SPNC | SPECTRANETICS CORP | $1,309,000 | +48.8% | 52,362 | 0.0% | 1.35% | +40.2% | |
| APPY | VENAXIS INC | $1,263,000 | +10.3% | 590,000 | 0.0% | 1.30% | +3.9% | |
| BSTC | BIOSPECIFICS TECHNOLOGIES | $1,120,000 | +11.3% | 51,692 | 0.0% | 1.15% | +4.9% | |
| ELOS | SYNERON MEDICAL LTD | $1,119,000 | +42.7% | 90,947 | 0.0% | 1.15% | +34.6% | |
| NUVASIVE INCnote 2.750% 7/0 | $1,092,000 | +12.1% | 1,000,000 | 0.0% | 1.12% | +5.6% | ||
| CRDC | CARDICA INC | $1,037,000 | -25.0% | 1,063,469 | 0.0% | 1.07% | -29.4% | |
| XNPT | Sell | XENOPORT INC | $1,020,000 | -6.1% | 177,362 | -7.3% | 1.05% | -11.5% |
| OGXI | New | ONCOGENEX PHARMACEUTICAL INC | $928,000 | – | 111,245 | +100.0% | 0.96% | – |
| CUTR | CUTERA INC | $903,000 | +14.4% | 88,694 | 0.0% | 0.93% | +7.8% | |
| CNAT | Buy | CONATUS PHARMACEUTICALS INC | $875,000 | -24.7% | 135,666 | +17.3% | 0.90% | -29.0% |
| JNJ | JOHNSON AND JOHNSON | $861,000 | +5.6% | 9,400 | 0.0% | 0.89% | -0.4% | |
| OCRX | Buy | OCERA THERAPEUTICS INC | $821,000 | +1125.4% | 63,223 | +700.9% | 0.84% | +1057.5% |
| ADMP | New | ADAMIS PHARMACEUTICALS CORP | $799,000 | – | 125,000 | +100.0% | 0.82% | – |
| UPI | UROPLASTY INC | $790,000 | -17.5% | 289,332 | 0.0% | 0.81% | -22.3% | |
| CLVS | New | CLOVIS ONCOLOGY INC | $759,000 | – | 12,600 | +100.0% | 0.78% | – |
| EXAC | Sell | EXACTECH INC | $752,000 | +10.9% | 31,636 | -5.9% | 0.77% | +4.5% |
| NSPR | Sell | INSPIREMD INC | $705,000 | -57.7% | 286,724 | -59.9% | 0.73% | -60.1% |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $655,000 | -1.2% | 9,598 | 0.0% | 0.67% | -6.9% | |
| DSCI | DERMA SCIENCES INC | $617,000 | -12.6% | 57,009 | 0.0% | 0.64% | -17.6% | |
| RTIX | RTI SURGICAL INC | $591,000 | -5.4% | 167,058 | 0.0% | 0.61% | -11.0% | |
| KERX | Sell | KERYX BIOPHARMACEUTICALS | $570,000 | -23.8% | 44,000 | -40.6% | 0.59% | -28.2% |
| DYAX | DYAX CORP | $569,000 | +9.8% | 75,500 | 0.0% | 0.59% | +3.5% | |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $568,000 | – | 290,000 | +100.0% | 0.58% | – |
| MASI | MASIMO CORPORATION | $512,000 | +9.9% | 17,500 | 0.0% | 0.53% | +3.5% | |
| CRIS | Sell | CURIS INC | $423,000 | -82.1% | 150,000 | -71.7% | 0.44% | -83.1% |
| BAXSQ | BAXANO SURGICAL INC | $340,000 | -27.4% | 336,351 | 0.0% | 0.35% | -31.5% | |
| TGTX | TG THERAPEUTICS INC | $293,000 | -22.5% | 75,000 | 0.0% | 0.30% | -26.9% | |
| SYN | New | SYNTHETIC BIOLOGICS INC | $283,000 | – | 184,900 | +100.0% | 0.29% | – |
| PTN | Sell | PALATIN TECHNOLOGIES INC | $253,000 | -1.9% | 344,690 | -8.0% | 0.26% | -7.8% |
| CEMI | New | CHEMBIO DIAGNOSTICS INC | $186,000 | – | 55,202 | +100.0% | 0.19% | – |
| RVP | New | RETRACTABLE TECHNOLOGIES INC | $62,000 | – | 20,000 | +100.0% | 0.06% | – |
| CBMXW | COMBIMATRIX CORP*w exp 05/01/201 | $1,000 | 0.0% | 2,325 | 0.0% | 0.00% | 0.0% | |
| ADAT | Exit | AUTHENTIDATE HOLDING CORP | $0 | – | -142,062 | -100.0% | -0.14% | – |
| TNXP | Exit | TONIX PHARMACEUTICALS HOLDIN | $0 | – | -45,000 | -100.0% | -0.18% | – |
| BIOL | Exit | BIOLASE INC | $0 | – | -111,604 | -100.0% | -0.23% | – |
| GRMH | Exit | GRAYMARK HEALTHCARE INC | $0 | – | -693,027 | -100.0% | -0.31% | – |
| IDRA | Exit | IDERA PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.38% | – |
| TGX | Exit | THERAGENICS CORP | $0 | – | -160,719 | -100.0% | -0.38% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS | $0 | – | -121,800 | -100.0% | -0.40% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -210,000 | -100.0% | -0.72% | – |
| CUR | Exit | NEURALSTEM INC | $0 | – | -312,500 | -100.0% | -0.92% | – |
| GALE | Exit | GALENA BIOPHARMA INC | $0 | – | -375,000 | -100.0% | -0.93% | – |
| KBIO | Exit | KALOBIOS PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -1.23% | – |
| Exit | WRIGHT MED GROUP INCnote 2.000% 8/1 | $0 | – | -1,000,000 | -100.0% | -1.34% | – | |
| ARIA | Exit | ARIAD PHARMACEUTICALS INC | $0 | – | -148,915 | -100.0% | -2.99% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.